Acer Therapeutics (ACER) PT Lowered to $9 at Roth Capital
Tweet Send to a Friend
Roth Capital analyst Yasmeen Rahimi lowered the price target on Acer Therapeutics (NASDAQ: ACER) to $9.00 (from $66.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
